Piper Sandler Raises Insulet (NASDAQ:PODD) Price Target to $310.00
Insulet (NASDAQ:PODD – Get Free Report) had its price objective boosted by analysts at Piper Sandler from $285.00 to $310.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has an “overweight” rating on the medical instruments supplier’s stock. Piper Sandler’s target price would suggest a potential upside of 9.62% from […]
Insulet (NASDAQ:PODD – Get Free Report) had its price objective boosted by analysts at Piper Sandler from $285.00 to $310.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has an “overweight” rating on the medical instruments supplier’s stock. Piper Sandler’s target price would suggest a potential upside of 9.62% from […]
